pycnodysostosis
Conditions
Interventions
Group A:600 mg of Total Glucosides of White Peony Capsules (State Drug Approval No. H20055058, produced by Lansen Pharmaceutical Holdings., China) were taken three times per day for one month
10 mg of Thymopeptide Eneric-Coated Capsules (State Drug Approval No. 19991132, Shanghai Baolong Pharmaceutical Holdings, China) were taken three times per day for one month
saline rinse with local iodophors treatment weekly till the wound was healed.
Sponsors
School of Stomatology, The Fourth Military Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: individual with clinical features of pycnodysostosis and mutation of CTSK gene
Exclusion criteria
Exclusion criteria: No Restriction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum IL-17A (pg/mL);Ratio(CD3+ CD4+/ CD3+ CD8+);exposed surface of alveolar bone;Swelling and pain in infraorbital region; | — |
Countries
China
Contacts
Public ContactXiaohong Duan
Outcome results
None listed